NCT04761198 - A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions

Solid Tumor, AdultAdvanced Solid TumorMetastatic Solid Tumor

Interventions

DRUG

Etigilimab

IV infusion of IV etigilimab every 2 weeks

DRUG

Nivolumab

IV infusion of nivolumab every 2 weeks

Trial Locations (16)

10065

Mereo Investigator Site, New York

22031

Mereo Investigator Site, Fairfax

27710

Mereo Investigator Site, Durham

32224

Mereo Investigator Site, Jacksonville

37203

Mereo Investigator Site, Nashville

48109

Mereo Investigator Site, Ann Arbor

55905

Mereo Investigator Site, Rochester

73104

Mereo Investigator Site, Oklahoma City

77030

Mereo Investigator Site, Houston

84119

Mereo Investigator Site, West Valley City

85054

Mereo Investigator Site, Phoenix

90025

Mereo Investigator Site, Los Angeles

94904

Mereo Investigator Site, Greenbrae

02215

Mereo Investigator Site, Boston

Unknown

Royal Marsden, London

Sarah Cannon UK, London